Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Liminal BioSciences Inc.
LMNL
Healthcare
Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed...
for trading on the Nasdaq Global Market.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LMNL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Post by
stockbuphoon
on Feb 09, 2022 9:55am
Running LMNL into the ground
Amazing that they received 70% of voucher money and spending it all on extended analysis of a Phase 1 MAD study and GALBRAITH's preclinical molecule trials. They are not even trying to hide that
...more
(40)
•••
balain
X
View Profile
View Bullboard History
Comment by
balain
on Feb 07, 2022 3:35pm
RE:Balain interesting post was this also posted on
You bet edrose, posted on Zymeworks as well! it's good to have a better understanding of who we are dealing with. Zymeworks shareholders may not have a clue of Galbraith's track record at
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(6)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Feb 07, 2022 3:19pm
Balain interesting post was this also posted on
Zymeworks site this will come out during questioning under oath at discovery in 2022 even if they try to delay tactics judge will have say on defendants tactics after all facts presented
...more
(40)
•••
balain
X
View Profile
View Bullboard History
Post by
balain
on Feb 07, 2022 2:02am
How is Ken Galbraith leading the turnaround at Zymeworks???
Why Ken Galbraith? Zymeworks was owned by institutions at 82% before the recent financing, 18% by retail. After the dilution, 62% institutions, 35% retail. These latest numbers clearly show that
...more
(22)
•••
4Justice
X
View Profile
View Bullboard History
Post by
4Justice
on Feb 05, 2022 1:32pm
NO MONEY FROM 4050 without settlement
wow! Every day trading volume is under $50,000! Too exciting this stock! Yes Thomvest must have been happy that Boehringer did not following its $1 billion letter of intent in August 2018. Thomvest
...more
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Feb 05, 2022 10:11am
RE:The stock that seems to never die
It's in its final death throes with more delays on 4050 aka "penicillin" that has all of a sudden gone terribly wrong and seems to be worthless. How convenient would that be for Thomson
...more
(3)
•••
PLIImfoservice
X
View Profile
View Bullboard History
Post by
PLIImfoservice
on Feb 05, 2022 4:54am
The stock that seems to never die
Is it to late to say "Happy New Year" to everyone PS Have a good weekend
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Jan 30, 2022 10:47pm
RE:RE:Deal for PBI1402 this week
Yes, I think you could be right but it seems suspicious in light of the timing now. Why is this important at this time? If there is no value in 4050, why would they even bother with precursor to 4050?
...more
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Jan 30, 2022 6:47pm
RE:RE:RE:Gunner why do you think zymeworks never mentioned anything
Sad that I dont realize he failed. Instead of reading posts, try to comprehend what is said. Of course he failed miserably at Liminal duh. That is why he doesn't have it on his resume
...more
(529)
•••
Dibah420
X
View Profile
View Bullboard History
Comment by
Dibah420
on Jan 30, 2022 12:39pm
RE:Deal for PBI1402 this week
buphoon: You've asked some half a dozen questions here, some repeated in different words, but all questioning a $400k payment to PL. Is it possible that you have overlooked a single, simple
...more
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Post by
stockbuphoon
on Jan 30, 2022 9:55am
Deal for PBI1402 this week
Why did they give Pierre Laurin $400k upfront royalties on PBI1402 to "clean this up." Why now when they are pulling all of the 4050 indications from clinical trial planning? Is this not
...more
(40)
•••
balain
X
View Profile
View Bullboard History
Comment by
balain
on Jan 29, 2022 11:06pm
RE:RE:Gunner why do you think zymeworks never mentioned anything
Gunner, it is sad that YOU of all people don't realize that he failed miserably at Liminal... Zymeworks hires him as new CEO and introduce him like he is a saviour of companies, someone who brings
...more
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Comment by
GunnerG
on Jan 28, 2022 12:38pm
RE:Gunner why do you think zymeworks never mentioned anything
Well I would say because it was not something he wants on his resume. What is your point why Zymeworks did not say anything about Liminal? No one seems to care except you.
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Jan 28, 2022 12:29am
RE:Gunner why do you think zymeworks never mentioned anything
And better, why does GunnerG care about Galbraith so much? And still bashing PLI from 2017! Even as an investor over those years? With his wife as he told us lol ? Any alarm bells going off on where
...more
(6)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Jan 27, 2022 10:14pm
Gunner why do you think zymeworks never mentioned anything
About Galbraith being ceo at luminal and what a great job he did
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >